Camlin Fine Sciences logo

Camlin Fine Sciences financials and balance sheet

NSE: CAMLINFINEBSE: 532834Chemicals & PetrochemicalsSmall Cap

Last close ₹80.53down ₹3.23 (3.86%)BSE ₹80.36

Share price at the NSE close on 23 Oct 2026. Previous close ₹83.76.

52-week range of traded prices to 23 Oct 2026
₹78.80Low, 23 Oct 2026₹204.57High, 23 Oct 2025
Market cap
₹1,547 Cr1,056th largest listed
P/E
263.0
P/E without one-offs
Lossover the last 12 months
P/B
1.5
Dividend yield
Nonein the last 12 months
ROE
0.6%
ROE without one-offs
−2.4%
ROCE
0.6%
Debt to equity
0.67
Volume, NSE
7,32,39442.1% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Camlin Fine Sciences annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Back to profit in the year to Mar 2026, ₹24 CrA loss in 4 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 3.5% of operating profit in the first full year.

The years either side of a change of basis do not compare. From the year to Mar 2025, the company's revenue for that year, ₹1,667 Cr, differs from its quarters added, ₹1,690 Cr; the company reports a discontinued business. From the year to Mar 2026, the company's revenue for that year, ₹1,723 Cr, differs from its quarters added, ₹1,765 Cr.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,723
  2. Materials and goods−922
  3. Employee costs−244
  4. Other expenses−450
  5. Operating profit107
  6. Depreciation−71
  7. Other income+29
  8. One-off items−25
  9. Finance costs−73
  10. Profit before tax−34
  11. Tax+0.5
  12. Joint ventures+1.7
  13. Discontinued businesses+55
  14. Net profit24

What the company owns

  • Plant, investments and other assets₹1,294 Cr
  • Inventory₹504 Cr
  • Receivables₹373 Cr
  • Cash and bank₹153 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,001 Cr
  • Borrowings₹668 Cr
  • Owed to suppliers₹505 Cr
  • Other liabilities₹150 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Camlin Fine Sciences quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 30 MayMar 2020Filed 20 JunMar 2021Filed 29 MayMar 2022Filed 20 MayMar 2023Filed 23 MayMar 2024Filed 21 MayMar 2025Filed 12 JunMar 2026Filed 26 May
Revenue from operations5347238921,0491,1871,4121,6821,6131,6671,723
5017108249181,0051,2591,4761,5391,4581,616
Materials and goods bought261422475534583759813914849922
Employee costs––88100120145163179192244
Other expenses––261285301355500447417450
Operating profit before depreciation33136913118215320574208107
Operating margin6.2%1.7%7.7%12.5%15.3%10.8%12.2%4.6%12.5%6.2%
Materials, % of revenue––53.2%50.9%49.2%53.8%48.4%56.6%51.0%53.5%
Employee costs, % of revenue––9.9%9.5%10.1%10.3%9.7%11.1%11.5%14.2%
Other expenses, % of revenue––29.2%27.2%25.4%25.1%29.8%27.7%25.0%26.1%
Depreciation and amortisation22272933445663796471
Operating profit after depreciation11−14409813897143−514436
Other income15121435336161429
Finance costs302837433836596010073
Profit before one-off items and tax−4−3117581059490−4959−8
One-off items000000−10−50−10−25
Profit before tax−4−3117581059480−9949−34
3−71428403441600
Share of profit of joint ventures and associates0–00–0––02
Profit from discontinued businesses––––––––−20855
−14−24330656040−105−15824
Other comprehensive income––11114−82018−123
Total comprehensive income––4311795360−87−17027
Net margin−2.7%−3.3%0.3%2.8%5.5%4.3%2.4%−6.5%––
Net margin without joint ventures and associates−2.6%–0.3%2.8%–4.3%––––
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank. Belonging to the company's shareholders is left blank for the year to Mar 2018: the filing's earnings per share does not match the profit it states, and cannot be multiplied back into the owners' profit because the share count moved by more than 5% across the period. Net margin is left blank for the years to Mar 2025 and Mar 2026: the profit includes the result of a business the company has discontinued, which the revenue does not, so the two make no margin.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 30 MayMar 2020Filed 20 JunMar 2021Filed 29 MayMar 2022Filed 20 MayMar 2023Filed 23 MayMar 2024Filed 21 MayMar 2025Filed 12 JunMar 2026Filed 26 May
4304607137658248578751,001
3714036437488198659021,041
Share capital1212131616171919
Reserves3593916317328048488831,022
Belonging to outside owners of subsidiaries595770175−8−27−40
432490490623780658646668
467548478595793732846974
189226291440443362303349
1,0871,2341,4821,8002,0601,9522,0242,324
4145596879079729518401,087
6726757958911,0869991,1831,234
Net debt325425352480680564454515
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 29 MayMar 2022Filed 20 MayMar 2023Filed 23 MayMar 2024Filed 21 MayMar 2025Filed 12 JunMar 2026Filed 26 May
117145511392782
1531767118765106
Of which working capital−656−13932−7837
Tax paid−36−30−20−48−38−24
Capital spending84214144614258
Free cash flow34−68−9378−1625
−133−249−125−66−75−53
3913660−8672−25
Dividends paid500000
Shares bought back000000
Shares issued7595002230
Net change in cash2332−14−13244
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Camlin Fine Sciences dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 30 MayMar 2020Filed 20 JunMar 2021Filed 29 MayMar 2022Filed 20 MayMar 2023Filed 23 MayMar 2024Filed 21 MayMar 2025Filed 12 JunMar 2026Filed 26 May
Earnings per share−₹1.40−₹0.38₹0.05₹2.50₹4.13₹4.65₹3.45−₹5.58−₹8.03₹1.46
Diluted earnings per share−₹1.40−₹0.37₹0.05₹2.50₹3.68₹4.56₹3.41−₹5.50−₹7.94₹1.42
Book value per share––₹30.59₹33.25₹50.46₹47.64₹52.16₹51.64₹47.98₹54.19
Shareholder yield––––−4.1%−4.3%0.0%0.0%−7.1%0.0%
Market cap at the year end (₹ crore)9241,2276034731,7042,1892,0021,4953,1521,862

Ratios

Consolidated, years to March.Camlin Fine Sciences PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 30 MayMar 2020Filed 20 JunMar 2021Filed 29 MayMar 2022Filed 20 MayMar 2023Filed 23 MayMar 2024Filed 21 MayMar 2025Filed 12 JunMar 2026Filed 26 May
Revenue growth9.1%35.4%23.4%17.6%13.1%19.0%19.1%−4.1%––
Operating profit growth−63.9%−62.1%447.0%90.4%39.2%−16.0%34.3%−64.0%––
Net profit growth–––892.4%119.1%−7.6%−34.1%–––
Earnings per share growth–––4,900.0%65.2%12.6%−25.8%–––
––0.2%7.8%9.7%8.7%6.6%−11.0%−15.7%2.8%
–––7.7 pts1.9 pts−1.0 pts−2.1 pts−17.7 pts−4.7 pts18.6 pts
From the net margin–––6.8 pts3.8 pts0.0 pts−2.4 pts−19.0 pts––
From asset turnover–––0.7 pts−0.4 pts−0.2 pts0.1 pts1.0 pts––
From borrowing–––0.2 pts−1.5 pts−0.9 pts0.3 pts0.4 pts––
Return on capital employed––4.6%10.3%11.4%7.0%8.9%−0.3%9.5%2.2%
Cash conversion––––179.6%240.9%127.9%––348.6%
Interest cover0.4–1.12.33.72.72.4–1.40.5
Debt to equity––1.001.060.690.810.950.770.740.67
Receivable days––8688837766657279
Inventory days––219204200178255205226199
Payable days––13111999112129130162200
Cash conversion cycle, days––17417318414319214013678
Working capital days––141118122101123113114100
Asset turnover––0.820.900.870.860.870.800.840.79
Assets per rupee of net worth––2.933.002.592.362.462.382.252.24
Sales per rupee of plant––4.285.162.462.932.122.132.812.76
Capital spending to depreciation––––1.893.822.310.770.660.81
Plant being built, % of plant in use––25.7%86.5%4.9%44.6%5.1%6.0%1.6%5.3%
Interest cover is left blank for the years to Mar 2018 and Mar 2024: operating profit after depreciation is a loss, and a loss covers no interest bill. From the net margin, from asset turnover and from borrowing are left blank for the years to Mar 2025 and Mar 2026: the profit of this year or the year before includes a business the company has discontinued while its revenue does not, so the change in return on equity is not split into margin, turnover and borrowing. Revenue growth and operating profit growth are left blank for the year to Mar 2025: between the two periods the company restated its earlier figures and the company began reporting a business as discontinued, so the two are on different bases and the change is not worked out. Revenue growth and operating profit growth are left blank for the year to Mar 2026: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
1.3%
Cash from operations against operating profit
76.8%
Measure10 years5 years3 years
Revenue growth, yearly rate13.4%7.7%0.8%
Profit growth, yearly rate−2.6%−11.5%−19.1%
Return on equity, average–−1.7%−8.0%
Return on capital employed, average–5.4%3.8%
Operating margin, average9.0%9.3%7.8%
Asset turnover, average–0.830.81
Cash conversion cycle, days, average–138118
Interest cover, average–1.81.0
Debt to equity, average–0.790.72

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations44424882
Cash from investing−569−195−53
Cash from financing157−38−25
Capital spending51916158
Dividends paid000
Shares bought back000
Shares issued for cash3182230
Borrowings raised2819469
Borrowings repaid1708817

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––635365
Altman Z-scorePublished threshold 1.812.222.053.373.062.732.353.522.39
Beneish M-scorePublished threshold −1.78––−2.65−2.27−2.80−2.96−2.30−2.30
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––5.9510.005.88−8.84−5.51−0.26
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––1.90–––
Receivables growth less revenue growthOur threshold 0 percentage points–3.18−6.07−8.25−17.44−2.3111.7910.24
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−7.96−1.99−14.2746.12−22.109.81−13.01
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–−0.940.560.991.48−0.401.764.52
Assets under construction, years of additionsOur threshold 2 years of additions–6.360.073.830.111.09–0.32
Effective tax ratePublished threshold 17.16 per cent81.7148.7437.8135.7150.47–0.14–
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––3.4425.34–−77.71–
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
7 Jan 2026India Ratings and Research Private Limited (opens in a new tab)Bank loan facilitiesIND BBB-; IND A3Review, DowngradeStable469.92
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.